CytoDyn Inc. , a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, today announced that A. Bruce Montgomery, M.D. has been appointed to the board of directors effective September 27, 2013.
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20131003006341&newsLang=en&ndmConfigId=1000639&vnsId=41
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20131003006341&newsLang=en&ndmConfigId=1000639&vnsId=41
No comments:
Post a Comment